Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice-Reference-Cited by-同舟云学术

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

Published:2003-07-01 Issue:1 Volume:112 Page:83-90
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Masuzaki Hiroaki,Yamamoto Hiroshi,Kenyon Christopher J.,Elmquist Joel K.,Morton Nicholas M.,Paterson Janice M.,Shinyama Hiroshi,Sharp Matthew G.F.,Fleming Stewart,Mullins John J.,Seckl Jonathan R.,Flier Jeffrey S.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference70 articles.

1. Obesity and the Regulation of Energy Balance

2. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines . Adipocyte-derived Bioactive Substances

3. Obesity and insulin resistance

4. Pathophysiological role of leptin in obesity-related hypertension

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production;Journal of Pharmacological Sciences;2024-04

2. Inhibition of the glucocorticoid‐activating enzyme 11β‐hydroxysteroid dehydrogenase type 1 drives concurrent 11‐oxygenated androgen excess;The FASEB Journal;2024-03-29

3. Obesity and Hypertension;Obesity;2024

4. 11β‐Hydroxysteroid dehydrogenase and the brain: Not (yet) lost in translation;Journal of Internal Medicine;2023-11-08

5. First in human randomised trial of J2H‐1702: A novel 11β‐hydroxysteroid dehydrogenase type 1 inhibitor for non‐alcoholic steatohepatitis treatment;Alimentary Pharmacology & Therapeutics;2023-09-25